Little is known about the relationship between steatosis, insulin resistance (IR) and metabolic syndrome (MS) in patients with hepatitis C (HCV) and/or human immunodeficiency virus (HIV) infections. The aim of this study was to ascertain the determinants of steatosis and of insulin resistance in virus-associated fatty liver disease and the role of HIV, HCV and HIV/HCV as modulators of the relationship between MS and IR
Fatty liver disease associated with epatiti C and/or human immunodeficiency virus: characterization of the link between hepatic steatosis, insulin resistance and metabolic syndrome / Guaraldi, Giovanni; A., Lonardo; S., Ballestri; S., Zona; C., Stentarelli; G., Orlando; F., Carli; Carulli, Lucia; A., Roverato; Loria, Paola. - In: HIV MEDICINE. - ISSN 1464-2662. - STAMPA. - 10:(2009), pp. 29-30. (Intervento presentato al convegno European AIDS Conference /EACS. tenutosi a Cologne nel 11.14.11.2009).
Fatty liver disease associated with epatiti C and/or human immunodeficiency virus: characterization of the link between hepatic steatosis, insulin resistance and metabolic syndrome.
GUARALDI, Giovanni;CARULLI, Lucia;LORIA, Paola
2009
Abstract
Little is known about the relationship between steatosis, insulin resistance (IR) and metabolic syndrome (MS) in patients with hepatitis C (HCV) and/or human immunodeficiency virus (HIV) infections. The aim of this study was to ascertain the determinants of steatosis and of insulin resistance in virus-associated fatty liver disease and the role of HIV, HCV and HIV/HCV as modulators of the relationship between MS and IR
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
